IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $1.09 billion. The enterprise value is $1.03 billion.
| Market Cap | 1.09B |
| Enterprise Value | 1.03B |
Important Dates
The next estimated earnings date is Monday, November 2, 2026, before market open.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Share Statistics
IRMD has 12.79 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 12.79M |
| Shares Outstanding | 12.79M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 34.85% |
| Owned by Institutions (%) | 63.02% |
| Float | 8.33M |
Valuation Ratios
The trailing PE ratio is 47.71 and the forward PE ratio is 39.23. IRMD's PEG ratio is 3.27.
| PE Ratio | 47.71 |
| Forward PE | 39.23 |
| PS Ratio | 12.65 |
| Forward PS | 10.87 |
| PB Ratio | 10.73 |
| P/TBV Ratio | 11.11 |
| P/FCF Ratio | 43.48 |
| P/OCF Ratio | 40.24 |
| PEG Ratio | 3.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.39, with an EV/FCF ratio of 41.12.
| EV / Earnings | 44.80 |
| EV / Sales | 11.96 |
| EV / EBITDA | 35.39 |
| EV / EBIT | 37.49 |
| EV / FCF | 41.12 |
Financial Position
The company has a current ratio of 9.46
| Current Ratio | 9.46 |
| Quick Ratio | 7.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.52% and return on invested capital (ROIC) is 50.37%.
| Return on Equity (ROE) | 23.52% |
| Return on Assets (ROA) | 15.56% |
| Return on Invested Capital (ROIC) | 50.37% |
| Return on Capital Employed (ROCE) | 26.04% |
| Weighted Average Cost of Capital (WACC) | 9.27% |
| Revenue Per Employee | $520,108 |
| Profits Per Employee | $138,886 |
| Employee Count | 166 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, IRMD has paid $6.69 million in taxes.
| Income Tax | 6.69M |
| Effective Tax Rate | 22.49% |
Stock Price Statistics
The stock price has increased by +21.41% in the last 52 weeks. The beta is 0.91, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +21.41% |
| 50-Day Moving Average | 87.39 |
| 200-Day Moving Average | 93.66 |
| Relative Strength Index (RSI) | 48.70 |
| Average Volume (20 Days) | 143,965 |
Short Selling Information
The latest short interest is 700,005, so 5.47% of the outstanding shares have been sold short.
| Short Interest | 700,005 |
| Short Previous Month | 697,251 |
| Short % of Shares Out | 5.47% |
| Short % of Float | 8.40% |
| Short Ratio (days to cover) | 6.77 |
Income Statement
In the last 12 months, IRMD had revenue of $86.34 million and earned $23.06 million in profits. Earnings per share was $1.79.
| Revenue | 86.34M |
| Gross Profit | 65.50M |
| Operating Income | 27.56M |
| Pretax Income | 29.75M |
| Net Income | 23.06M |
| EBITDA | 29.18M |
| EBIT | 27.56M |
| Earnings Per Share (EPS) | $1.79 |
Balance Sheet
The company has $59.08 million in cash and no debt, with a net cash position of $59.08 million or $4.62 per share.
| Cash & Cash Equivalents | 59.08M |
| Total Debt | n/a |
| Net Cash | 59.08M |
| Net Cash Per Share | $4.62 |
| Equity (Book Value) | 101.75M |
| Book Value Per Share | 7.96 |
| Working Capital | 77.56M |
Cash Flow
In the last 12 months, operating cash flow was $27.14 million and capital expenditures -$2.02 million, giving a free cash flow of $25.12 million.
| Operating Cash Flow | 27.14M |
| Capital Expenditures | -2.02M |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | n/a |
| Free Cash Flow | 25.12M |
| FCF Per Share | $1.96 |
Margins
Gross margin is 75.86%, with operating and profit margins of 31.92% and 26.70%.
| Gross Margin | 75.86% |
| Operating Margin | 31.92% |
| Pretax Margin | 34.45% |
| Profit Margin | 26.70% |
| EBITDA Margin | 33.80% |
| EBIT Margin | 31.92% |
| FCF Margin | 29.09% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 43.02% |
| FCF Payout Ratio | 39.20% |
| Buyback Yield | -0.41% |
| Shareholder Yield | 0.53% |
| Earnings Yield | 2.11% |
| FCF Yield | 2.30% |
Analyst Forecast
The average price target for IRMD is $118.00, which is 38.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $118.00 |
| Price Target Difference | 38.01% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 11.06% |
| EPS Growth Forecast (3Y) | 12.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 52.72 and a Piotroski F-Score of 5.
| Altman Z-Score | 52.72 |
| Piotroski F-Score | 5 |